Medicare Enrolled
Dr. James Libecco, MD
Dermatology · Fairlawn, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Libecco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Libecco?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Libecco
Dr. James Libecco is a dermatology specialist in Fairlawn, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Libecco performed 11,787 Medicare services across 3,205 unique beneficiaries.
Between the years covered by Open Payments, Dr. Libecco received a total of $1,088,694 from 59 pharmaceutical and/or device companies across 2045 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Libecco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in OH
$1,088,694 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,787
Medicare services
Top 4% in OH for dermatology
3,205
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~589 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, tildrakizumab, 1 mg | 5,900 | $110 | $200 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,320 | $5 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,249 | $55 | $125 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
731 | $35 | $100 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
355 | $63 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
289 | $80 | $175 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
217 | $74 | $140 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
157 | $37 | $75 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $34 | $100 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
77 | $113 | $250 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
62 | $215 | $400 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
59 | $10 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
54 | $53 | $175 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
30 | $111 | $400 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
30 | $49 | $175 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
29 | $1 | $6 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
24 | $307 | $450 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
18 | $189 | $400 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
17 | $30 | $100 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
15 | $130 | $225 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
14 | $225 | $415 |
| Surgical removal of skin cancer, 2.1-3.0 cm Surgical excision of a cancerous skin growth measuring 2.1 to 3.0 centimeters from the scalp, neck, hands, feet, or genitals. |
12 | $143 | $435 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
11 | $66 | $235 |
| Surgical removal of skin cancer, 3.1-4.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue is between 3.1 and 4.0 centimeters. |
11 | $142 | $455 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 11 | $132 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $98 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,088,694
Total received (2018-2024)
Avg $155,528/year across 7 years
Top 1% in OH for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
2,045
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,058,321 (97.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$24,167 (2.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,206 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$225,566
2023
$173,446
2022
$169,855
2021
$84,894
2020
$67,279
2019
$192,788
2018
$174,866
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$86,022
ABBVIE INC.
$31,529
UCB, Inc.
$25,627
Lilly USA, LLC
$24,645
Janssen Biotech, Inc.
$17,704
Galderma Laboratories, L.P.
$16,260
SUN PHARMACEUTICAL INDUSTRIES INC.
$14,591
Incyte Corporation
$3,590
Novartis Pharmaceuticals Corporation
$2,824
Dermavant Sciences, Inc.
$1,862
Regeneron Healthcare Solutions, Inc.
$152
REVANCE THERAPEUTICS, INC.
$123
GENZYME CORPORATION
$79
LEO Pharma Inc.
$75
Amgen Inc.
$71
PFIZER INC.
$70
Organon Llc
$67
Ortho Dermatologics, a division of Bausch Health US, LLC
$64
Mallinckrodt Hospital Products Inc.
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
Verrica Pharmaceuticals Inc.
$25
Merck Sharp & Dohme LLC
$17
Arcutis Biotherapeutics, Inc.
$17
CONMED Corporation
$16
Kyowa Kirin, Inc.
$15
Top 3 companies account for 63.5% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$172,378
Novartis Pharmaceuticals Corporation
$140,004
ABBVIE INC.
$128,121
E.R. Squibb & Sons, L.L.C.
$117,985
Janssen Scientific Affairs, LLC
$92,933
Sun Pharmaceutical Industries Inc.
$79,100
UCB, Inc.
$76,098
AbbVie, Inc.
$75,449
Janssen Biotech, Inc.
$40,584
Incyte Corporation
$29,224
SUN PHARMACEUTICAL INDUSTRIES INC.
$25,428
AbbVie Inc.
$24,849
Dermavant Sciences, Inc.
$24,156
Regeneron Healthcare Solutions, Inc.
$20,038
Galderma Laboratories, L.P.
$17,006
GENZYME CORPORATION
$13,888
LEO Pharma Inc.
$5,095
Ortho Dermatologics, a division of Bausch Health US, LLC
$2,955
PFIZER INC.
$472
Amgen Inc.
$347
Mayne Pharma Inc.
$307
Taro Pharmaceuticals USA, Inc.
$282
Biofrontera Inc.
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$129
REVANCE THERAPEUTICS, INC.
$123
DERMIRA, INC.
$118
Celgene Corporation
$109
Allergan, Inc.
$102
SANOFI-AVENTIS U.S. LLC
$100
Almirall LLC
$89
Arcutis Biotherapeutics, Inc.
$79
PruGen, Inc. Pharmaceuticals
$77
Kyowa Kirin, Inc.
$74
EPI Health, LLC
$70
Merz North America, Inc.
$69
Organon Llc
$67
VYNE Pharmaceuticals Inc.
$63
Mallinckrodt Hospital Products Inc.
$62
Genentech USA, Inc.
$56
Journey Medical Corporation
$54
Verrica Pharmaceuticals Inc.
$48
DUSA Pharmaceuticals, Inc.
$38
Helsinn Therapeutics (U.S.), Inc.
$34
Mission Pharmacal Company
$31
STRATA Skin Sciences, Inc.
$25
Mylan Pharmaceuticals Inc.
$22
MERZ NORTH AMERICA, INC.
$22
NOBELPHARMA AMERICA, LLC
$21
Sandoz Inc.
$20
MAYNE PHARMA COMMERCIAL LLC
$18
Merck Sharp & Dohme LLC
$17
Nabriva Therapeutics, plc
$16
CONMED Corporation
$16
Aclaris Therapeutics, Inc.
$16
Fresenius Kabi USA, LLC
$16
Allergan Inc.
$16
TARO PHARMACEUTICALS USA, INC.
$14
Myriad Genetic Laboratories, Inc.
$11
Encore Dermatology Inc.
$11
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ACTHAR · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Acticlate · Aczone · Ameluz · Avar · BLU-U · BOTOX · BOTOX COSMETIC · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Ceracade · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DAXXIFY · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · Exelderm · HADLIMA · HALOG · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · HYFTOR · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · KERYDIN · KEYTRUDA · LIBTAYO · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Olumiant · Otezla · Poteligeo · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VALCHLOR · VISICLEAR · VTAMA · Veltin · Winlevi · XELJANZ · XTRAC · Xolair · YCANTH · Zoryve · myPath
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for dermatology in OH.
Geographic Context
Dermatologists within 10 mi
130
Per 100K population
24.2
County median income
$71,016
Nearest hospital
SUMMA WESTERN RESERVE HOSPITAL
5.4 mi
5.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Libecco is a mixed practice specialist, with above-average Medicare volume (top 4% in OH), with speaking/promotional industry engagement in the top 1% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Libecco experienced with injection, tildrakizumab, 1 mg?
Based on Medicare claims data, Dr. Libecco performed 5,900 injection, tildrakizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Libecco receive payments from pharmaceutical companies?
Yes. Dr. Libecco received a total of $1,088,694 from 59 companies across 2,045 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Libecco's costs compare to other dermatologists in Fairlawn?
Dr. Libecco's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Libecco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Fairlawn
Browse dermatologists in Fairlawn ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in OH
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in OH
Which OH dermatologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology